WHAT IS ENVISION?

Envision addresses one of the fastest-growing, underserved markets: dry eye disease. It sets a new in-office standard for non-surgical procedures in delicate areas, enabling safe, highly efficacious treatment of the skin and subdermal layers of the face and periorbital region.

This intelligent, programmable platform delivers customizable, energy-based therapies for conditions such as dry eye associated with Meibomian Gland Dysfunction (MGD), while also improving skin quality and patient outcomes.

By targeting underlying causes rather than symptoms alone, Envision provides a minimally invasive solution that enhances ocular health, comfort, and overall appearance with little to no downtime. For clinics looking to diversify, medicalise their offering, and drive consistent income, Envision is a game changer.